Tonix Pharmaceuticals Holding Corp. Share Price
NASDAQ: TNXPHealthcare
Live Tonix Pharmaceuticals Holding Corp. Share Price Chart
O H L
Tonix Pharmaceuticals Holding Corp. Performance Overview
Days Range
▼
$11.20Low
$11.38High
Markets Today
| Previous Close | $11.42 |
|---|---|
| Open | $11.38 |
| Volume | 50,961 |
| Day's Range | $11.20 - $11.38 |
| 52W Range | $9.40 - $29.19 |
| Market Cap | $201.70 M |
Historical Performance
| 1M Returns | -9.79 |
|---|---|
| 3M Returns | -4.91 |
| 6M Returns | -19.52 |
| 1Y Returns | -59.75 |
| 5Y Returns | -100.00 |
| 10Y Returns | -100.00 |
Tonix Pharmaceuticals Holding Corp. Fundamentals
| Market Cap | $201.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $13.11 M |
| ROE TTM | -0.64 |
| EPS TTM | $-12.92 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.89 |
| EBITDA | $-123.78 M |
| Profit Margin | -946.22 |
| Market Cap | $201.70 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $13.11 M |
| ROE TTM | -0.64 |
| EPS TTM | $-12.92 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.89 |
| EBITDA | $-123.78 M |
| Profit Margin | -946.22 |
Tonix Pharmaceuticals Holding Corp. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $2.43 M | $2.00 M | $3.29 M | $5.39 M | $6.88 M | $13.54 M |
| Gross Profit + | $1.49 M | -$1.27 M | $1.92 M | $4.33 M | $5.30 M | $12.84 M |
| Operating Income | -$16.05 M | -$28.30 M | -$33.07 M | -$48.29 M | -$41.54 M | -$42.53 M |
| EBITDA | -$15.56 M | -$27.81 M | -$32.61 M | -$47.80 M | -$40.98 M | -$41.92 M |
| Interest Expense | $0 | $943.00 K | $0 | $0 | $0 | $1.43 M |
| Depreciation | $493.00 K | $483.00 K | $461.00 K | $488.00 K | $555.00 K | $619.00 K |
| Income Before Tax | -$16.83 M | -$28.27 M | -$32.01 M | -$46.91 M | -$40.19 M | -$40.55 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$16.83 M | -$28.27 M | -$32.01 M | -$46.91 M | -$40.19 M | -$40.55 M |
| Net Profit Margin | -692.84% | -1415.02% | -972.95% | -870.32% | -584.38% | -299.41% |
Tonix Pharmaceuticals Holding Corp. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $7.00 K | $8.00 K | $10.00 K | $13.00 K | $14.00 K | $17.00 K |
| Reserve & Surplus | -$747.79 M | -$776.07 M | -$808.08 M | -$855.00 M | -$895.19 M | -$935.81 M |
| Non-Current Liabilities | $328.00 K | $297.00 K | $266.00 K | $1.18 M | $1.13 M | $1.02 M |
| Current Liabilities | $12.15 M | $19.06 M | $21.03 M | $30.84 M | $29.65 M | $30.79 M |
| Total Liabilities | $12.47 M | $19.36 M | $21.30 M | $32.02 M | $30.77 M | $31.81 M |
| Fixed Assets | $41.89 M | $42.45 M | $42.69 M | $44.46 M | $45.01 M | $44.76 M |
| Current Assets | $149.57 M | $143.53 M | $208.07 M | $228.88 M | $207.17 M | $203.43 M |
| Total Assets | $192.87 M | $187.36 M | $252.44 M | $277.17 M | $257.91 M | $254.09 M |
Tonix Pharmaceuticals Holding Corp. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$16.83 M | -$28.27 M | -$32.01 M | -$46.91 M | -$40.19 M | -$40.55 M |
| Operating Cash Flow | -$16.58 M | -$14.83 M | -$28.78 M | -$39.65 M | -$42.32 M | -$42.24 M |
| Investing Cash Flow | -$6.00 K | -$2.54 M | -$962.00 K | -$1.02 M | -$1.69 M | -$587.00 K |
| Financing Cash Flow | $49.53 M | $10.99 M | $94.86 M | $59.14 M | $20.20 M | $33.51 M |
| Change in Cash | $32.94 M | -$6.38 M | $65.11 M | $18.46 M | -$23.80 M | -$9.39 M |
Tonix Pharmaceuticals Holding Corp. Return Calculator
The Tonix Pharmaceuticals Holding Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$0
Invested Amount$10,000
Est. Returns$-10,000
About Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
Popular Stocks
FAQs
What is the share price of Tonix Pharmaceuticals Holding Corp. today?
Tonix Pharmaceuticals Holding Corp. (TNXP) share price as of September 18, 2026 is $11.16. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Tonix Pharmaceuticals Holding Corp.?
Yes, Indian Investors can invest in the Tonix Pharmaceuticals Holding Corp. (TNXP) Share by opening an international trading account with Angel One.
How can I purchase Tonix Pharmaceuticals Holding Corp. shares in India?
Purchasing Tonix Pharmaceuticals Holding Corp. (TNXP) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Tonix Pharmaceuticals Holding Corp. (TNXP) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Tonix Pharmaceuticals Holding Corp.?
Yes, you can purchase fractional shares of Tonix Pharmaceuticals Holding Corp. (TNXP) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Tonix Pharmaceuticals Holding Corp.?
The market capitalization of Tonix Pharmaceuticals Holding Corp. on September 18, 2026, is $201.70 M.
In which sector Tonix Pharmaceuticals Holding Corp. belongs?
Tonix Pharmaceuticals Holding Corp. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Tonix Pharmaceuticals Holding Corp. stocks?
In order to invest in Tonix Pharmaceuticals Holding Corp. (TNXP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
